MLICM
ICAD

Metropolitan Life Insurance Company (MetLife)’s iCAD Inc ICAD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ICAD Stock Details ICAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,625
Closed -$115K – 2847
2021
Q2 		$115K Hold
6,625
– – ﹤0.01% 2525
2021
Q1 		$141K Sell
6,625
-148
-2% -$2.49K ﹤0.01% 2251
2020
Q4 		$89.4K Sell
6,773
-263
-4% -$2.84K ﹤0.01% 2406
2020
Q3 		$62K Sell
7,036
-134
-2% -$1.32K ﹤0.01% 2436
2020
Q2 		$71.6K Buy
+7,170
New +$77.4K ﹤0.01% 2431

Other funds holding ICAD

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ICAD Position: Q3 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of iCAD Inc (ICAD) in Q3 2021, closing a stake of 6,625 shares — an estimated $115K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ICAD in Q2 2020 and held it in 5 quarters. The position peaked at $141K in Q1 2021. 80 funds tracked by Wall St. Rank hold ICAD as of Q3 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining iCAD Inc position as of Q3 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,625 iCAD Inc shares in Q3 2021, an estimated $115K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in iCAD Inc in Q2 2020 and held it in 5 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s iCAD Inc position peaked at $141K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held iCAD Inc as of Q3 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.